dr. halmos on met mutations in patients with nsclc
Published 7 years ago • 263 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
1:16
dr. halmos on detecting actionable mutations in patients with lung cancer
-
13:06
met exon 14 mutations in mnsclc
-
1:35
dr. halmos on actionable biomarkers in nsclc
-
1:24
dr. halmos on recent advancements in non–small cell lung cancer
-
1:14
evaluating the role of egfr mutations in the treatment of advanced nsclc
-
1:11
dr. belani discusses driver mutations in nsclc
-
1:15
dr. halmos discusses immunotherapeutics in lung cancer
-
1:25
dr. halmos on the impact of egfr inhibitors on the treatment of lung cancer
-
4:07
her2- and met-mutation/amplification therapies
-
1:36
met as a clinical target in lung cancer
-
4:29
non–small cell lung cancer: other actionable mutations
-
1:37
dr. awad on acquired resistance to met inhibitors in nsclc
-
1:31
dr. akerley on met biomarker in lung cancer
-
4:10
crizotinib resistance in alk nsclc
-
6:46
treatment of egfr nsclc brain metastases
-
5:18
nsclc management: second-line options
-
1:28
dr. camidge on met as a target in lung cancer
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
1:18
dr. umamaheswar duvvuri on impact of multiple genetic mutations in advanced thyroid cancer